In this video, Colby Holtshouse from May Health breaks down a critical reality: there is currently no single holistic solution for Polycystic Ovary Syndrome, a condition affecting 1 in 10 women of reproductive age.

Despite affecting millions of women worldwide, PCOS still has no approved therapies specifically for the condition — leaving many patients managing symptoms without targeted treatment. In this short video, Alpha Lee, CSO and Co-Founder of PostEra, explains how PostEra is approaching this challenge.

This report outlines the current challenges and new opportunities in PCOS drug development. Join the conversation on how we can catalyze collaborative efforts to accelerate the development of evidence-based, mechanism-driven therapies that improve outcomes and quality of life for women living with PCOS.

On 5 June 2025, NG Bio and the Artemis WH Foundation co-hosted the "XXplore Women's Health" event in London, focused on accelerating healthcare innovation for the benefit of women.

Kaitlin DeMarco from Locust Walk sheds light on current trends in venture capital and how they impact the fundraising for Women’s Health startups. She describes how a changing environment creates new opportunities in Women’s Health and how entrepreneurs can position their company to attract the right investors.

Foreground Capital has a clear mission: to fuel innovation in Women’s Health - a space still underserved by most other investment funds. In this interview, Stasia Obremskey shares practical, insider advice for Women’s Health startups looking to make their mark.